Angela Hwang is a member of Pfizer’s Executive Team and Group President of the Pfizer Biopharmaceuticals Group, which comprises 80% of Pfizer’s revenues. Her organization of 26,000 colleagues is responsible for bringing over 600 innovative medicines and products to patients. In 2019, more than 290 million people benefited from a Pfizer Biopharma medicine or vaccine to improve their health and, in some cases, save their lives. Altogether, Pfizer Biopharma generated more than $38 billion in 2018 revenues.

As Group President of Pfizer Biopharma, Hwang leads 7 commercial business units, reaching patients in more than 125 countries. Together, these businesses strive to deliver transformational medicines that address major global health priorities in cancer, rare disease, inflammation & immunology, primary care, infectious diseases, and preventative care with vaccines.

Hwang has been with Pfizer for 23 years, working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.

Hwang sits on the boards of EFPIA (European Federation of Pharmaceutical Industries and Associations), as well as the Pfizer Foundation, a charitable organization that addresses global health challenges. She has also been active in industry groups such as BIO, where she previously co-chaired the Vaccines Policy Committee. In 2019, she was named in Crain’s Notable Women in Healthcare list.

Having always been curious about transformation and the art of the possible, in 2019, Hwang launched Diverse Perspectives, a podcast series where she hosts global thought leaders pioneering change across a variety of industries. You can learn more about Diverse Perspectives here, and subscribe on iTunes, Spotify, and other streaming platforms.

Hwang received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and MBA from Cornell University. She is a wife and proud mom to a teenage son and daughter, and a strong advocate for women’s leadership and sustainable global health equity.

Pharmaceutical, Health, Healthcare, Healthcare Policy, Business of Healthcare, Business Leadership, Female Leadership, Influential Women, Women in Business, Leadership, World Economic Forum,